| Literature DB >> 21672218 |
Lydia V Rump1, Markus Fischer, Narjol Gonzalez-Escalona.
Abstract
BACKGROUND: Insertion elements (IS) are known to play an important role in the evolution and genomic diversification of Escherichia coli O157:H7 lineages. In particular, IS629 has been found in multiple copies in the E. coli O157:H7 genome and is one of the most prevalent IS in this serotype. It was recently shown that the lack of O157 antigen expression in two O rough E. coli O157:H7 strains was due to IS629 insertions at 2 different locations in the gne gene that is essential for the O antigen biosynthesis.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21672218 PMCID: PMC3271280 DOI: 10.1186/1471-2180-11-133
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Figure 1Stepwise evolutionary model for [11]. In red letters are the possible events happening and where they occurred during the stepwise evolution. The circle in gray represents an intermediary A3 CC, which has not yet been isolated. SOR - sorbitol fermentation [if (+) fermenting, if (-) non-fermenting or slow fermenting]. GUD - β-D-glucuronidase activity.
Prevalence of IS629 elements in each strain (chromosomes and plasmids) and number of shared IS629
| Strain | Serotype | IS | In common with strain | |||||
|---|---|---|---|---|---|---|---|---|
| Sakai | EDL933 | EC4115 | TW14359 | CB9615 | ||||
| O157:H7 | 19 | - | 13 | 9 | 9 | 0 | ||
| O157:H7 | 21 | 13 | - | 6 | 6 | 0 | ||
| O157:H7 | 19 | 9 | 6 | - | 17 | 0 | ||
| O157:H7 | 21 | 9 | 6 | 17 | - | 0 | ||
| O55:H7 | 1 | 0 | 0 | 0 | 0 | - | ||
| O157:H7 | 3 | - | 3 | 3 | 3 | 0 | ||
| O157:H7 | 3 | 3 | - | 3 | 3 | 0 | ||
| O157:H7 | 4 | 3 | 3 | - | 4 | 0 | ||
| O157:H7 | 4 | 3 | 3 | 4 | - | 0 | ||
| O157:H- | 0 | 0 | 0 | 0 | 0 | 0 | ||
| O55:H7 | 1 tr* | 0 | 0 | 0 | 0 | - | ||
tr* - truncated.
Serotype, sequence type, characteristics and isolation information of strains of E. coli used in this study
| No. | Name | Other name | Serotype |
| Special characteristics | ST | CC | Source | Year | Reference | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GUD | SOR | plasmid | ||||||||||
| 1 | Sakai | BAA 460 | O157:H7 | 1, 2 | - | - | pO157 | 66 | A6 | Japan | 1996 | NC_002695 |
| 2 | EDL 933 | 700927 | O157:H7 | 1,2 | - | - | pO157 | 66 | USA | 1982 | AE005174 | |
| 3 | EC 4115 | O157:H7 | 1, 2 | - | - | pO157 | 66 | USA | 2006 | NC_011353 | ||
| 4 | TW 14359 | O157:H7 | 1, 2 | - | - | pO157 | 66 | USA | 2006 | CP001368 | ||
| 5 | EDL 931 | 35150 | O157:H7 | 1, 2 | - | - | pO157 | 66 | [ | |||
| 6 | MA6 | O157:H7 | 2 | - | - | pO157 | 66 | Malaysia | 1998 | [ | ||
| 7 | 550654 | O157:H7 | 2 | - | - | pO157 | 66 | USA | 2009 | |||
| 8 | FDA 413 | O157:H7 | 2 | - | - | pO157 | 66 | [ | ||||
| 9 | G5101 | O157:H7 | 1, 2 | + | - | pO157 | 65 | A5 | USA | 1995 | [ | |
| 10 | 1628 | O157:H7 | 1, 2 | + | - | pO157 | 65 | [ | ||||
| 11 | 1659 | O157:H7 | 1, 2 | + | - | pO157 | 65 | [ | ||||
| 12 | EC 97144 | TW 10707 | O157:H7 | 1, 2 | + | + | pO157 | 65 | Japan | 1997 | [ | |
| 13 | EC 96038 | TW 10201 | O157:H7 | 1, 2 | + | + | pO157 | 65 | [ | |||
| 14 | EC 96012 | TW 10189 | O157:H7 | 1, 2 | + | + | pO157 | 65 | [ | |||
| 15 | 493-89 | O157:H- | 2 | + | + | pSFO157 | 75 | A4 | Germany | 1989 | [ | |
| 16 | 5412-89 | O157:H- | 2 | + | + | pSFO157 | 75 | Germany | 1989 | [ | ||
| 17 | H56929 | TW 09159 | O157:H- | 2 | + | + | pSFO157 | 76 | Finland | 1999 | [ | |
| 18 | H56909 | TW 09162 | O157:H- | 2 | + | + | pSFO157 | 76 | Finland | 1999 | [ | |
| 19 | H 1085c | O157:H- | 2 | + | + | pSFO157 | 76 | Scotland | 2003 | [ | ||
| 20 | H 2687 | O157:H- | 2 | + | + | pSFO157 | 76 | Scotland | 2003 | [ | ||
| 21 | 3256-97 | TW 07815 | O55:H7 | 2 | + | + | ? | 73 | A2 | USA | 1997 | [ |
| 22 | USDA 5905 | O55:H7 | 2 | + | + | ? | 73 | USA | 1994 | [ | ||
| 23 | TB 182A | TW 04062 | O55:H7 | - | + | + | ? | 73 | A1 | USA | 1991 | [ |
| 24 | DEC5A | O55:H7 | - | + | + | ? | 73 | [ | ||||
| 25 | LSU-61 | O157:H7 | - | + | + | ? | 237 | ? | USA | 2001 | NC_002695 | |
| 26 | Sakai PF | O157:H7 | 1, 2 | - | - | pO157 | 66 | A6 | Japan | 1996 | AE005174 | |
| 27 | 43895 | CDC | O157:H7 | 1,2 | - | - | pO157 | 69 | A6 | USA | 1982 | |
stx - shiga toxin gene, GUD - β-glucuronidase activity, SOR - sorbitol fermentation, ST - sequence type as determined by a combination of seven genes http://www.shigatox.net/stec/cgi-bin/index, CC - Clonal complex [11], ? - Unknown. Sakai PF and 43895 are strain derived after numerous subculture passages from the original Sakai and EDL933 strains, respectively.
Figure 2Gel-electrophoresis of the PCR products for IS. Lanes: Ld, molecular weight ladder (Gene Ruler); wt, Blank; 1 - 25, strains numbered according to Table 2. A1-A6, Clonal complexes, A?, CC unknown.
IS629 element presence/absence in CC strains from the O157:H7 stepwise evolutionary model
| A6 | A5 | A4 | A2 | A1 | A? | A6 | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IS.1 | Sp 4 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS.2 | Sp 4 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS. 3 | Sp 5 stx2 | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS. 4 | SpLE 1 | - | + | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 5 | SpLE 1 | + | + | + | + | + | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 6 | SpLE 1 | - | + | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 7 | SpLE 1 | + | + | + | + | + | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 8 | Sp 8 | + | - | + | - | + | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS. 9 | Sp 8 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + |
| IS. 10 | back | + | + | - | - | + | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 11 | back | + | + | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 12 | Sp 12 | + | - | - | - | - | - | - | - | - | - | - | + | + | + | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS. 13 | back | + | + | + | + | + | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 14 | Sp 13 | + | + | + | + | + | + | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 15 | Sp 14 | + | + | + | + | + | + | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS.16 | SpLE 2 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS. 17 | back | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 18 | Sp 15 stx1 | + | + | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 19 | back | + | - | + | + | + | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS. 20 | Sp 17 | + | - | + | + | + | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS. 21 | SpLE3 | + | + | - | + | + | + | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS.22 | back | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS. 23 | SpLE 5 | + | + | - | - | + | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 24 | SpLE 1 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + |
| IS. 25 | SpLE 1 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + |
| IS.26 | 933O | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS. 27 | SpLE 2 | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + |
| IS.28 | 933Y | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS. 29 | Sp 1 | - | - | + | + | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 30 | Sp 4 | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 31 | Phage | - | - | + | + | - | - | - | - | + | + | - | + | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 32 | back | - | - | + | + | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 33 | Sp 13 | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 34 | back | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 35 | Sp 5 stx 2 | - | - | + | + | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS.36 | back | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS. 37 | Phage | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS. 38 | back | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 39 | ( | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 40 | pO157 | + | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - |
| IS. 41 | pO157 | + | + | + | + | + | + | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS. 42 | pO157 | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | + |
| IS.43 | ||||||||||||||||||||||||||||
| IS. 44 | pO157 | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 45 | pO157 | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS. 46 | back | - | - | - | + | - | - | - | - | + | + | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| IS.47 | back | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND |
| IS.48 | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | ND | |
IS629 sites were numbered from 1 - 47 (NR) starting with all sites in Sakai, followed by all additional, unshared sites from EDL933, EC4115, the sites found in the plasmids and unshared sites of strain TW1435. The newly found IS629 insertion in O rough:H7 strain MA6 was numbered IS.39 [4]. A1 - A6 are strains belonging to the different clonal complexes.
Sp - Phage; SpLE - Phage-like element; back - backbone; ND -Not determined, primers failed to amplify the region.
Figure 3Evolutionary significance of IS. A) Maximum parsimony tree obtained using the distribution of IS629 and IS629 target sites in the 14 O157:H7 strains analyzed in the present study (Table 3 and Additional file 4, Table S3). B) Maximum parsimony tree obtained using IS629 target sites for the 27 strains analyzed in the present study (Additional file 4, Table S3). The colored ellipses mark the different CCs. CC - clonal complex; ST - sequence type.
Presence of IS629 target sites on the backbone
| IS | A1 | A2 | A3 | A4 | A5 | A6 |
|---|---|---|---|---|---|---|
| | + | + | + | |||
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | - | - | + | + |
NA, not applicable; + presence; - absence; +/- present in some strains.
Presence of phage or phage-like associated IS629 target sites
| IS | A1 | A2 | A3 | A4 | A5 | A6 |
|---|---|---|---|---|---|---|
| | _ | _ | _ | _ | + | |
| | + | + | + | + | + | |
| | + | + | + | + | + | |
| | _ | _ | _ | _ | + | |
| | _ | _ | _ | _ | + | |
| | _ | + | + | + | + | |
| | _ | _ | _ | _ | + | |
| | _ | _ | + | + | + | |
| | _ | _ | _ | _ | + | |
| | _ | _ | _ | + | + | |
| | _ | _ | _ | _ | + | |
| | _ | _ | _ | _ | + | |
| | _ | _ | _ | + | + |
Sp - Phage; SpLE - Phage-like element; NA - not applicable; + presence; - absence.
Figure 4Phylogenetic tree of IS. IS629 sub-type I differed from sub-type II by 4% (> 55 bp) and sub-type II differed from sub-type III by 5% (> 60 bp). IS629 sub-type II was only present in O55:H7 genome (A1/A2 CC) while sub-type I and III were present in all O157:H7 genomes (A6 CC). The evolutionary history was inferred using the Minimum Evolution method [31]. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. Bootstrap support when above 50% is shown at nodes. Sp- prophages; SpLE - prophage-like elements; and back - backbone.